Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes.

Boudreau LH, Maillet J, LeBlanc LM, Jean-François J, Touaibia M, Flamand N, Surette ME.

PLoS One. 2012;7(2):e31833. doi: 10.1371/journal.pone.0031833. Epub 2012 Feb 9.

2.

5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.

Rask-Madsen J, Bukhave K, Laursen LS, Lauritsen K.

Agents Actions. 1992;Spec No:C37-46. Review.

PMID:
1359745
3.

5-Lipoxygenase: a target for antiinflammatory drugs revisited.

Steinhilber D.

Curr Med Chem. 1999 Jan;6(1):71-85. Review.

PMID:
9873115
4.

Caffeic acid phenethyl ester and therapeutic potentials.

Murtaza G, Karim S, Akram MR, Khan SA, Azhar S, Mumtaz A, Bin Asad MH.

Biomed Res Int. 2014;2014:145342. doi: 10.1155/2014/145342. Epub 2014 May 29. Review.

5.

The potential usage of caffeic acid phenethyl ester (CAPE) against chemotherapy-induced and radiotherapy-induced toxicity.

Akyol S, Ginis Z, Armutcu F, Ozturk G, Yigitoglu MR, Akyol O.

Cell Biochem Funct. 2012 Jul;30(5):438-43. doi: 10.1002/cbf.2817. Epub 2012 Mar 20. Review.

PMID:
22431158
6.

Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.

Drazen JM.

Pharmacotherapy. 1997 Jan-Feb;17(1 Pt 2):22S-30S. Review.

PMID:
9017785
7.

5-Lipoxygenase inhibitors: a review of recent patents (2010-2012).

Hofmann B, Steinhilber D.

Expert Opin Ther Pat. 2013 Jul;23(7):895-909. doi: 10.1517/13543776.2013.791678. Epub 2013 Apr 21. Review.

PMID:
23600432
8.

Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: a review on its anti-inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects.

Tolba MF, Azab SS, Khalifa AE, Abdel-Rahman SZ, Abdel-Naim AB.

IUBMB Life. 2013 Aug;65(8):699-709. doi: 10.1002/iub.1189. Epub 2013 Jul 11. Review.

9.
10.

Recent advances in the search for novel 5-lipoxygenase inhibitors.

Steinhilber D, Hofmann B.

Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):70-7. doi: 10.1111/bcpt.12114. Epub 2013 Sep 18. Review.

11.

In vivo and in vitro antıneoplastic actions of caffeic acid phenethyl ester (CAPE): therapeutic perspectives.

Akyol S, Ozturk G, Ginis Z, Armutcu F, Yigitoglu MR, Akyol O.

Nutr Cancer. 2013;65(4):515-26. doi: 10.1080/01635581.2013.776693. Review.

PMID:
23659443
12.

Bioactivity and chemical synthesis of caffeic acid phenethyl ester and its derivatives.

Zhang P, Tang Y, Li NG, Zhu Y, Duan JA.

Molecules. 2014 Oct 13;19(10):16458-76. doi: 10.3390/molecules191016458. Review.

13.

Future opportunities in preventing ototoxicity: Caffeic acid phenethyl ester may be a candidate (Review).

Akyol S, Isik B, Altuntas A, Erden G, Cakmak O, Kurşunlu SF, Adam B, Akyol O.

Mol Med Rep. 2015 Sep;12(3):3231-5. doi: 10.3892/mmr.2015.3785. Epub 2015 May 14. Review.

PMID:
25975288
14.

Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents.

Werz O, Gerstmeier J, Garscha U.

Expert Opin Ther Pat. 2017 May;27(5):607-620. doi: 10.1080/13543776.2017.1276568. Epub 2017 Jan 5. Review.

PMID:
28005436
15.

Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils.

Flamand N, Boudreault S, Picard S, Austin M, Surette ME, Plante H, Krump E, Vallée MJ, Gilbert C, Naccache P, Laviolette M, Borgeat P.

Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 2):S88-94. Review. No abstract available.

PMID:
10673234
16.

Melatonin and caffeic acid phenethyl ester in the regulation of mitochondrial function and apoptosis: The basis for future medical approaches.

Erdemli HK, Akyol S, Armutcu F, Gulec MA, Canbal M, Akyol O.

Life Sci. 2016 Mar 1;148:305-12. doi: 10.1016/j.lfs.2016.01.026. Epub 2016 Jan 16. Review.

PMID:
26784848
17.

Leukotriene modifiers: novel therapeutic opportunities in asthma.

Buccellati C, Fumagalli F, Viappiani S, Folco G.

Farmaco. 2002 Mar;57(3):235-42. Review.

PMID:
11989802
18.

Antileukotriene agents for the treatment of lung disease.

Scott JP, Peters-Golden M.

Am J Respir Crit Care Med. 2013 Sep 1;188(5):538-44. doi: 10.1164/rccm.201301-0023PP. Review.

PMID:
23822826
19.

The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.

Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW.

Int J Immunopharmacol. 1992 Apr;14(3):505-10. Review.

PMID:
1618602
20.

5-lipoxygenase inhibitors and their anti-inflammatory activities.

Batt DG.

Prog Med Chem. 1992;29:1-63. Review.

PMID:
1475368

Supplemental Content

Support Center